Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes.
about
Different maturation cocktails provide dendritic cells with different chemoattractive properties.Intralymphatic immunotherapyIRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity.Efficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route.Enhancement of dendritic cells as vaccines for cancerIL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.Peptide-based vaccines for cancer: realizing their potential.Dendritic cells in cancer immunotherapy clinical trials: are we making progress?Novel therapeutics for the treatment of metastatic melanoma.The evolving role of dendritic cells in cancer therapy.mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic.mRNA-based dendritic cell vaccines.The ReNAissanCe of mRNA-based cancer therapy.Effective immunotherapy of weakly immunogenic solid tumours using a combined immunogene therapy and regulatory T-cell inactivation.Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer.Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?Update on Dendritic Cell-Induced Immunological and Clinical Tolerance.
P2860
Q30315866-0501A4FE-6944-4CAF-B3ED-95004E549300Q35155423-D4672EEC-3777-4FC4-AAEF-AA6F35CF4A9FQ35156105-37254C24-11E5-45F3-84DE-5FD24A8D5561Q35224721-8F64AF69-A4CD-4FA5-A682-4F63D6975C45Q36209210-EA12F48C-B07F-49DC-9BBB-AF1833EFB8B8Q37052943-74731C45-B9BE-4971-9B56-2B189D2F9657Q37340462-0F89BA9E-65F5-4AFC-8B7D-6808EDDEB1B5Q37389096-FB904669-29C4-4C62-963C-6A728FA00301Q37486788-BC500324-0FC6-4042-B190-33823C78C41DQ37687418-FEE4D398-75F7-4100-9B91-3DBC8DC38894Q38071900-47ED3D54-87AB-491B-933B-14B6785212A8Q38246769-70B3A4EA-6AA8-488B-9537-D5995CE58F2DQ38255012-96C98D5C-BB0A-4005-AC25-EA466B48DBD3Q39734928-3B396BD2-0357-4415-8B4C-735F67F1DF02Q40320557-5DECAC88-F72D-47E7-8AEF-DE0F7DC98837Q41520681-9560C4B6-27C4-44D8-BC94-90C127CD0487Q47121682-67630E5F-0D87-400C-A81D-83ED9AE18DD2
P2860
Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Intralymphatic dendritic cell ...... ic, skin-homing T lymphocytes.
@ast
Intralymphatic dendritic cell ...... ic, skin-homing T lymphocytes.
@en
type
label
Intralymphatic dendritic cell ...... ic, skin-homing T lymphocytes.
@ast
Intralymphatic dendritic cell ...... ic, skin-homing T lymphocytes.
@en
prefLabel
Intralymphatic dendritic cell ...... ic, skin-homing T lymphocytes.
@ast
Intralymphatic dendritic cell ...... ic, skin-homing T lymphocytes.
@en
P2093
P2860
P1476
Intralymphatic dendritic cell ...... ic, skin-homing T lymphocytes.
@en
P2093
Amelia Grover
Grace J Kim
Gregory Lizée
John R Wunderlich
Mary Tschoi
Patrick Hwu
Sam T Hwang
Steven A Rosenberg
P2860
P304
P356
10.1158/1078-0432.CCR-05-2421
P407
P577
2006-10-01T00:00:00Z